Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and irritated, and the itching can be so severe that it interferes with sleep and ...
Between an unrelenting itch that interrupts sleep and the social challenges of rashes that can appear anywhere on the body without warning, atopic dermatitis has many ways of raising a person’s stress ...
ORLANDO, Fla. — In a phase 3 atopic dermatitis (AD) trial, rocatinlimab, a novel therapy that targets T cells expressing the OX40 receptor, showed efficacy on both coprimary and key secondary ...
Please provide your email address to receive an email when new articles are posted on . Rezpegaldesleukin is a first-in-class interleukin-2 receptor agonist that proliferates and activates regulatory ...
—Shared pathogenesis between atopic dermatitis, vitiligo, and alopecia areata supports a unified approach that targets these common mechanisms, promising better treatment options for these ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (TTRX) (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results